Global Restless Legs Syndrome Market: Overview

Restless legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It triggers an urge in patients to move their legs. Because the syndrome usually occurs during sleep, it is also considered a type of sleep disorder. People suffering from RLS often feel an overwhelming desire to rigorously move their legs, due to which they feel an unpleasant pain in their limbs. This eventually disturbs their sleep patterns, affecting their health adversely. The condition usually aggravates at night when the patient is at rest.
To access full report, please visit : http://www.transparencymarketresearch.com/restless-legs-syndrome-market.html

A higher prevalence of RLS is noted in women than in men. RLS can affect people of all ages but the syndrome mostly affects middle-aged and elderly people. The most common symptoms of RLS include uncomfortable itching and pain in the legs that may cause a disruption in the sleep pattern and ultimately affect a patient’s quality of life. Despite its increasing prevalence, the precise cause of RLS is not yet known. Nevertheless, with extensive investigations conducted in the field, the RLS market is expected to gain momentum in the near future. As of now, experts attribute genetic factors, instabilities in the dopaminergic balance, or low levels of iron to the increasing incidence of the syndrome.

While researchers are yet to discover a specific cure for the disorder, drugs presently available in the market ensure symptomatic treatment. They help in relieving the uneasiness commonly experienced in the disorder. The report studies the prospects for the global restless legs syndrome market in the forthcoming years. The impact of research and development activities on the market’s future outlook is examined in the report in detail. It also presents insights into the various social and economic factors that will influence the market’s growth trajectory between 2016 and 2024.

Global Restless Legs Syndrome Market: Opportunities and Market Segmentation

Restless legs syndrome causes uneasiness in patients and is also associated with other health issues such as dizziness, headaches, drowsiness, flatulence, dry mouth, and nausea. Psychiatric disorders such as depression and a decreased libido are also faced by patients suffering from RLS. Apart from these, nutritional and metabolism disorders, including weight gain, increased appetite, labyrinth disorders, ear disorders, fatigue, irritability, and peripheral edema are also related to the syndrome.

The treatment of restless legs syndrome is still a relatively untapped space. This provides immense opportunities for the RLS market to tap into. The market is projected to report growth at an increased rate with the development of new drugs that promise higher efficiency and minimum side effects.

Based on product type, the global restless legs syndrome market can be segmented into Neupro/Leganto, Mirapex/Sifrol/Mirapexin, HORIZANT/Regnite, and Requip. On the basis of disease type the market can be broadly classified into genetic factors, etiology and pathogenesis, neurological disturbances, iron deficiency, and others. The two most commonly used modes of therapy are pharmacological and nonpharmacological therapy.

Global Restless Legs Syndrome Market: Competitive Insight

In order to study the competition prevailing in the market, the report also profiles companies such as GlaxoSmithKline plc., Kyowa Hakko Kirin Co., Boehringer Ingelheim GmbH, Jazz Pharmaceuticals, Inc., and Manhattan Pharmaceuticals. The strengths and weaknesses of the companies are weighed out in the report using SWOT analysis. The analysis also helps the report gauge threats and opportunities that these companies could face in the near future.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12506

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â [email protected]
Website: http://www.transparencymarketresearch.com/